News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) Rejects Idea of Buying AstraZeneca PLC (AZN)


5/4/2012 6:56:55 AM

Triangle Business Journal by Lauren K. Ohnesorge, Staff Writer

British drug maker GlaxoSmithKline (Nasdaq: GSK) will not be buying smaller rival AstraZeneca (NYSE: AZN). That’s according to GSK CEO Andrew Witty, who told shareholders Thursday that buying a company AstraZeneca’s size would be “distracting,” Reuters reports.

GSK has its U.S. headquarters in Research Triangle Park.

While it doesn’t have a large presence in the Triangle like GSK, AstraZeneca is well known among local drug makers, including partnering with them on occasion.


Read at Reuters
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES